Literature DB >> 17327054

[Endothelium-dependent vasodilation in patients with obstructive sleep apnea-hypopnea syndrome].

Zan-feng Wang1, Xue-wei Feng, Jian Kang.   

Abstract

OBJECTIVE: To evaluate the endothelial function in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS) by measuring the brachial artery diameter during reactive hyperemia.
METHODS: Thirty patients with OSAHS (8 with mild and 22 with moderate/severe OSAHS) and 10 control subjects were studied. Brachial artery diameter was measured with Doppler ultrasound under baseline conditions, during reactive hyperemia (an endothelium-dependent dilatation) and after sublingual administration of nitroglycerin (an endothelium-independent vasodilator). The dilative rate of brachial artery in different conditions was calculated to evaluate the endothelial function.
RESULTS: The dilative rate of brachial artery in the control group, the mild OSAHS group and the moderate/severe OSAHS group were (15.2 +/- 2.6)%, (14.3 +/- 3.2)% and (9.8 +/- 4.9)%, respectively. There was a significant decrease of endothelium-dependent flow-mediated dilation in the moderate/severe OSAHS group compared to the control group and the mild OSAHS group. No significant difference in endothelium-independent vasodilator after sublingual administration of nitroglycerin was found among the three groups.
CONCLUSION: Patients with moderate/severe OSAHS have impaired endothelium-dependent vasodilatation, and OSAHS itself maybe a risk factor for endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17327054

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  1 in total

1.  Treatment and prevention of inflammatory responses and oxidative stress in patients with obstructive sleep apnea hypopnea syndrome using Chinese herbal medicines.

Authors:  Qin Chen; Rong Jing Lin; Xuchu Hong; Lin Ye; Qichang Lin
Journal:  Exp Ther Med       Date:  2016-06-27       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.